Song C, Zhao X, Li S, Guo X, et al. Durvalumab combined with concurrent chemoradiotherapy in patients with limited-stage small cell lung cancer: A prospective, single-arm, phase 2 clinical trial. Cancer 2026;132:e70351.
PMID: 41832629